Patient-reported outcomes in the Translational Breast Cancer Research Consortium.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 31743427.
- Also identified by DOI 10.1002/cncr.32615 and PMC identifier 7063688.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.
Medical subject headings
- Breast Neoplasms
- Clinical Trials as Topic
- Patient Reported Outcome Measures
- Quality of Life
- Surveys and Questionnaires